Advertisement
Review Article| Volume 26, ISSUE 1, P1-12, March 2006

The Changing Indications of Gastrointestinal Decontamination in Poisonings

  • Kennon Heard
    Correspondence
    Division of Emergency Medicine, University of Colorado School of Medicine, 4200 East 9th Avenue, B215, Denver, CO 80262.
    Affiliations
    Division of Emergency Medicine, University of Colorado School of Medicine, Denver, CO, USA

    Medical Toxicology, University of Colorado School of Medicine, Denver, CO, USA

    Rocky Mountain Poison and Drug Center, Denver, CO, USA
    Search for articles by this author
      Gastrointestinal (GI) decontamination is the therapy that is most commonly administered to patients who have had acute oral exposure to poisons. These techniques were used in almost 200,000 poisoning cases reported to North American Poison Centers in 2001 [
      • Watson W.A.
      • Litovitz T.L.
      • Klein-Schwartz W.
      • et al.
      2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.
      ]. The theory behind GI decontamination is simple: poisons that are not absorbed into the blood cannot cause systemic toxicity. This principle has been recognized since the fifth century bc [
      • Wax P.
      Historical principles and perspectives.
      ]; hence decontamination has become accepted without rigorous scientific data. Over the past several years, as practitioners demand quality data to guide treatment decisions, we have observed a deconstruction of “standard” poisoning management. The purpose of this article is to describe the commonly used techniques of decontamination, review the literature that describes their efficacy, and, finally, provide summary recommendations for the use of GI decontamination in the treatment of poisoned patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Watson W.A.
        • Litovitz T.L.
        • Klein-Schwartz W.
        • et al.
        2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.
        Am J Emerg Med. 2004; 22: 335-404
        • Wax P.
        Historical principles and perspectives.
        in: Goldfrank L.S. Flomenbaum N.E. Lewin N.A. Goldfrank's toxicologic emergencies. McGraw-Hill, New York2003: 1-22
        • Anonymous
        Position paper: ipecac syrup.
        J Toxicol Clin Toxicol. 2004; 42: 133-143
        • Albertson T.E.
        • Derlet R.W.
        • Foulke G.E.
        • et al.
        Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions.
        Ann Emerg Med. 1989; 18: 56-59
        • Kulig K.
        • Bar-Or D.
        • Cantrill S.V.
        • et al.
        Management of acutely poisoned patients without gastric emptying.
        Ann Emerg Med. 1985; 14: 562-567
        • Pond S.M.
        • Lewis-Driver D.J.
        • Williams G.M.
        • et al.
        Gastric emptying in acute overdose: a prospective randomised trial.
        Med J Aust. 1995; 163: 345-349
        • Anonymous
        Poison treatment in the home. American Academy of Pediatrics Committee on Injury, Violence, and Poison Prevention.
        Pediatrics. 2003; 112: 1182-1185
        • Vale J.A.
        Position statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
        J Toxicol Clin Toxicol. 1997; 35: 711-719
        • Grierson R.
        • Green R.
        • Sitar D.S.
        • et al.
        Gastric lavage for liquid poisons.
        Ann Emerg Med. 2000; 35: 435-439
        • Saetta J.P.
        • March S.
        • Gaunt M.E.
        • et al.
        Gastric emptying procedures in the self-poisoned patient: are we forcing contents beyond the pylorus?.
        J R Soc Med. 1991; 84: 274-276
        • Merigian K.S.
        • Woodard M.
        • Hedges J.R.
        • et al.
        Prospective evaluation of gastric emptying in the self-poisoned patient.
        Am J Emerg Med. 1990; 8: 479-483
        • Thompson A.M.
        • Robins J.B.
        • Prescott L.F.
        Changes in cardiorespiratory function during gastric lavage for drug overdose.
        Hum Toxicol. 1987; 6: 215-218
        • Olkkola K.T.
        Effect of charcoal–drug ratio on antidotal therapy efficacy of oral activated charcoal in man.
        Br J Clin Pharmacol. 1985; 19: 767-773
        • Chyka P.A.
        • Seger D.
        Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
        J Toxicol Clin Toxicol. 1997; 35: 721-741
        • Green R.
        • Grierson R.
        • Sitar D.S.
        • et al.
        How long after drug ingestion is activated charcoal still effective?.
        J Toxicol Clin Toxicol. 2001; 39: 601-605
        • Laine K.
        • Kivisto K.T.
        • Neuvonen P.J.
        Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil.
        J Toxicol Clin Toxicol. 1997; 35: 263-268
        • Yeates P.J.
        • Thomas S.H.
        Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose.
        Br J Clin Pharmacol. 2000; 49: 11-14
        • Green R.
        • Sitar D.S.
        • Tenenbein M.
        Effect of anticholinergic drugs on the efficacy of activated charcoal.
        J Toxicol Clin Toxicol. 2004; 42: 267-272
        • Roberts J.R.
        • Gracely E.J.
        • Schoffstall J.M.
        Advantage of high-surface-area charcoal for gastrointestinal decontamination in a human acetaminophen ingestion model.
        Acad Emerg Med. 1997; 4: 167-174
        • Krenzelok E.P.
        • Heller M.B.
        Effectiveness of commercially available aqueous activated charcoal products.
        Ann Emerg Med. 1987; 16: 1340-1343
        • Merigian K.S.
        • Blaho K.E.
        Single-dose oral activated charcoal in the treatment of the self- poisoned patient: a prospective, randomized, controlled trial.
        Am J Ther. 2002; 9: 301-308
        • Cooper G.M.
        • Le Couteur D.G.
        • Richardson D.
        • et al.
        A randomised controlled trial of activated charcoal for the routine management of oral drug overdose.
        J Toxicol Clin Toxicol. 2002; 40 ([abstract]): 313
        • Crome P.
        • Adams R.
        • Ali C.
        • et al.
        Activated charcoal in tricyclic antidepressant poisoning: pilot controlled clinical trial.
        Hum Toxicol. 1983; 2: 205-209
        • Buckley N.A.
        • Whyte I.M.
        • O'Connell D.L.
        • et al.
        Activated charcoal reduces the need for N-acetylcysteinetreatment after acetaminophen (paracetamol) overdose.
        J Toxicol Clin Toxicol. 1999; 37: 753-757
        • Seger D.
        Single-dose activated charcoal—back up and reassess.
        J Toxicol Clin Toxicol. 2004; 42: 101-110
        • Arnold T.C.
        • Willis B.H.
        • Xiao F.
        • et al.
        Aspiration of activated charcoal elicits an increase in lung microvascular permeability.
        J Toxicol Clin Toxicol. 1999; 37: 9-16
        • Moll J.
        • Kerns II, W.
        • Tomaszewski C.
        • et al.
        Incidence of aspiration pneumonia in intubated patients receiving activated charcoal.
        J Emerg Med. 1999; 17: 279-283
        • Liisanantti J.
        • Kaukoranta P.
        • Martikainen M.
        • et al.
        Aspiration pneumonia following severe self-poisoning.
        Resuscitation. 2003; 56: 49-53
        • Pollack M.M.
        • Dunbar B.S.
        • Holbrook P.R.
        • et al.
        Aspiration of activated charcoal and gastric contents.
        Ann Emerg Med. 1981; 10: 528-529
        • Wallace K.L.
        • Curry S.C.
        • LoVecchio F.
        • et al.
        Effect of magnesium hydroxide in iron absoption following simulated mild overdose in human subjects.
        Acad Emerg Med. 1998; 5: 961-965
        • Snyder B.K.
        • Clark R.F.
        Effect of magnesium hydroxide administration on iron absorption after a supratherapeutic dose of ferrous sulfate in human volunteers: a randomized controlled trial.
        Ann Emerg Med. 1999; 33: 400-405
        • Belanger D.R.
        • Tierney M.G.
        • Dickinson G.
        Effect of sodium polystyrene sulfonate on lithium bioavailability.
        Ann Emerg Med. 1992; 21: 1312-1315
        • Tomaszewski C.
        • Musso C.
        • Pearson J.R.
        • et al.
        Lithium absorption prevented by sodium polystyrene sulfonate in volunteers.
        Ann Emerg Med. 1992; 21: 1308-1311
        • Henderson R.P.
        • Solomon C.P.
        Use of cholestyramine in the treatment of digoxin intoxication.
        Arch Intern Med. 1988; 148: 745-746
        • Idid S.Z.
        • Lee C.Y.
        Effects of Fuller's Earth and activated charcoal on oral absorption of paraquat in rabbits.
        Clin Exp Pharmacol Physiol. 1996; 23: 679-681
        • Barceloux D.
        • McGuigan M.
        • Hartigan-Go K.
        Position statement: cathartics. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
        J Toxicol Clin Toxicol. 1997; 35: 743-752
        • Ambrose N.S.
        • Johnson M.
        • Burdon D.W.
        • et al.
        A physiological appraisal of polyethylene glycol and a balanced electrolyte solution as bowel preparation.
        Br J Surg. 1983; 70: 428-430
        • Anonymous
        Position paper: whole bowel irrigation.
        J Toxicol Clin Toxicol. 2004; 42: 844-854
        • Scharman E.J.
        • Lembersky R.
        • Krenzelok E.P.
        Efficiency of whole bowel irrigation with and without metoclopramide pretreatment.
        Am J Emerg Med. 1994; 12: 302-305
        • Ly B.T.
        • Schneir A.B.
        • Clark R.F.
        Effect of whole bowel irrigation on the pharmacokinetics of an acetaminophen formulation and progression of radio-opaque markers through the gastrointestinal tract.
        Ann Emerg Med. 2004; 43: 189-195
        • Smith S.W.
        • Ling L.J.
        • Halstenson C.E.
        Whole-bowel irrigation as a treatment for acute lithium overdose.
        Ann Emerg Med. 1991; 20: 536-539
        • Tenenbein M.
        • Cohen S.
        • Sitar D.S.
        Whole bowel irrigation as a decontamination procedure after acute drug overdose.
        Arch Intern Med. 1987; 147: 905-907
        • Tenenbein M.
        Whole bowel irrigation as a gastrointestinal decontamination procedure after acute poisoning.
        Med Toxicol. 1988; 3: 77-84
        • Buckley N.
        • Dawson A.H.
        • Howarth D.
        • et al.
        Slow-release verapimil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium.
        Med J Aust. 1993; 158: 202-204
        • Hoffman R.S.
        • Smilkstein M.J.
        • Goldfrank L.R.
        Whole bowel irrigation and the cocaine body packer: a new approach to a common problem.
        Am J Emerg Med. 1990; 8: 523-527
        • Marschall H.U.
        • Bartels F.
        Life-threatening complications of nasogastric administration of polyethylene glycol-electrolyte solutions (Golytely) for bowel cleansing.
        Gastrointest Endosc. 1998; 47: 408-410